Although T cells were also sensitive to lower doses of the inhibitor (1.9–2.5 μM) to induce cell death (Figure S6B), 0.5 μM SP-2509 did not impair cytokine release by CAR T cells and was sufficient to upregulate FAS at the tumor site (Figure S6C). This evidence concerns the gene FAS and neoplasm.